Non-cirrhotic portal hypertension in Human Immunodeficiency Virus- infected patients: A new challenge in antiretroviral therapy era

Open AIDS Journal

Volumn 5, Issue 1, 2011, Pages 59-61

  Díaz, Hortensia Álvarez ^a   Callejo, Ana Mariño ^a   Rodríguez, José Francisco García ^a  

^a Universidad de La Coruña   (Spain)

Author keywords

Didanosine; HIV; Portal hypertension

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE; AMINOTRANSFERASE; ATAZANAVIR PLUS RITONAVIR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEIN C; PROTEIN S; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; BLOOD TOXICITY; BLOOD TRANSFUSION; CASE REPORT; CAUCASIAN; CD4 LYMPHOCYTE COUNT; CHOLESTASIS; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONDYLOMA ACUMINATUM; DOPPLER ECHOGRAPHY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ESOPHAGUS ULCER; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOPHOSPHATEMIA; IRON DEFICIENCY ANEMIA; LIPOATROPHY; LIVER FIBROSIS; LIVER HYPERPLASIA; LUNG TUBERCULOSIS; MALE; NON CIRRHOTIC PORTAL HYPERTENSION; PNEUMOCYSTIS PNEUMONIA; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SPLENOMEGALY; THRUSH; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; VEIN LIGATION; VIRUS LOAD;

EID: 80053535547     PISSN: None     EISSN: 18746136     Source Type: Journal    
DOI: 10.2174/1874613601105010059     Document Type: Article

References (12)

1. Saifee S, Joelson D, Braude J, et al. Noncirrhotic portal hypertension in patients with Human Immunodeficiency Virus-1 Infection. Clin Gastroenterol Hepatol 2008; 6(10): 1167-9.
2. Maida I, Vispo E, Sotgiu G, et al. Unexplained severe portal hypertension in HIV-infected patients: a new clinical entity? J Int AIDS Soc 2008, 11(Suppl 1): P138.
3. Ferlitsch A, Teml A, Reinisch W, et al. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension. Am J Gastroenterol 2007; 102: 2495-503.
4. Pol S. Cryptogenetic liver disease, steatosis, portal hypertension, transaminitis and antiretrovirals. J Int AIDS Soc 2008; 11(Suppl 1): O24.
5. Schiano TD, Kotler DP, Ferran E, et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007; 102(11): 2536-40.
6. Maida I, Núñez M, Ríos MJ, et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006; 42(2): 177-82.
7. Chang PE, Garcia-Pagan JC. Idiopathic noncirrhotic portal hypertension in HIV-infected patients. Clin Infect Dis 2010; 50(1): 127-8.
8. Kovari H, Ledergerber B, Peter U, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 2009; 49: 626-35.
9. Maida I, Garcia-Gasco P, Sotgiu G, et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antiviral Ther 2008; 13: 103-107.
10. Guidelines for the use of Antiretroviral Agents in HIV-1-infected adults and adolescents. United States Department of Health and Human Services (DHHS). Appendix B, Table 1. Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) December 1, 2009.
11. Tateo M, Sebagh M, Bralet MP, et al. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl 2008; 14: 1194-8.
12. Álvarez H, Mariño A, Garcia-Rodriguez FJ. Thrombotic events in Human Immunodeficiency Virus-infected patients: revisiting an emerging issue. Infect Dis Clin Pract 2009; 17(4): 264-5.